Table of Content

Part 1. Summary
Part 2. Introduction
? Study period
? Geographical scope
? Market segmentation
Part 3. Clinical next-generation sequencing market overview
Part 4. Market breakdown by component
? Instrument
? Workflow solution (kits, services, etc.)
Part 5. Market breakdown by disease class
? Cancer
? Non-cancer
Part 6. Market breakdown by disease category
? Cardiovascular
? Clinical microbiology and infectious diseases
? Mendelian disorders
? Metabolic/immune
? Neurological
? Oncology
? Reproductive health
? Transplantation
Part 7. Market breakdown by test complexity
? Hotspot
? Multi-gene
? Single gene
? Whole genome
? Whole/targeted exome
Part 8. Market breakdown by test purpose
? Diagnosis
? Monitoring
? Screening/early detection
? Therapy guidance
Part 9. Market breakdown by region
? Asia Pacific
? Europe
? North America
? Rest of the World (RoW)
Part 10. Key companies
? ANGLE plc
? Becton, Dickinson and Company
? BGI Group
? Biocept,?Inc.
? Biodesix,?Inc.
? Biolidics Limited
? Bio-Techne Corporation
? Burning Rock Biotech Limited
? CareDx,?Inc.
? Danaher Corp.
? Epigenomics AG
? Eurofins Scientific?SE
? EXACT Sciences Corporation
? Fulgent Genetics Inc.
? GeneDx Inc.
? Guardant Health,?Inc.
? Illumina, Inc.
? Koninklijke Philips N.V.
? Merck KGaA
? Myriad Genetics, Inc.
? NeoGenomics Laboratories, Inc.
? Qiagen N.V.
? Quest Diagnostics Incorporated
? Roche Holding AG
? Thermo Fisher Scientific Inc.
Part 11. Methodology